Status:
RECRUITING
Sequential Analysis in Patients With an Hemopathy
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Hemopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Recent advances in hematology clearly illustrate that the simple "clonal" nature of various hematological malignancies may not really reflect the reality of malignant cells natural expansion. This has...
Eligibility Criteria
Inclusion
- Patients with a malignant hematological disease.
- Signed written informed consent
- Age and Sex : men and women aged 18 years or older
- Patients affiliated to a social security system
Exclusion
- \- Patients protected by law, in accordance with Articles L1121-L1121-5 to 8 of the Code of Public Health.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
246 Patients enrolled
Trial Details
Trial ID
NCT02260739
Start Date
January 1 2014
End Date
January 1 2026
Last Update
August 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gustave Roussy
Villejuif, Val de Marne, France, 94805